Public recall detail

Panhematin powder for solution: Sterility concern

2024-09-13

medium
Recall Safety notice
Quick summary

Quick summary: Panhematin powder for solution: Sterility concern. Date: 2024-09-13.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Panhematin powder for solution: Sterility concern. Date: 2024-09-13.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandRecordati Rare Diseases Canada
ProductPanhematin 268 mg/vial powder for solution
IssueHealth products - Product quality
Recall classType I
IdentificationRA-76042

Affected products

BrandRecordati Rare Diseases Canada
ProductPanhematin powder for solution
DIN / NPN / authorizationDIN 02478765
Dosage formPowder for Solution
StrengthHemin 268 mg/vial
Lot485407C

Issue

Product sterility may be compromised in affected lot.

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceHealthcare Hospitals
CategoryHealth products - Biologic or vaccine
CompaniesRecalling firm: Recordati Rare Diseases Canada (care of McKesson Specialized Distribution) 8449 Lawson Rd, Unit 102 Milton, Ontario L9T 9L1 Canada Market authorization holder: Recordati Rare Diseases Canada Inc. 3080 Yonge Street, Suite 6060 Toronto, Ontario, M4N 3N1 Canada
Published byHealth Canada
Recall classType I
Alert / recall typeHealth product recall
Identification numberRA-76042
Background{}
CompaniesRecalling firm: Recordati Rare Diseases Canada (care of McKesson Specialized Distribution) 8449 Lawson Rd, Unit 102 Milton, Ontario L9T 9L1 Canada Market authorization holder: Recordati Rare Diseases Canada Inc. 3080 Yonge Street, Suite 6060 Toronto, Ontario, M4N 3N1 Canada
AudiencesHealthcare Hospitals
Source updated2024-09-13

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...